BEAMSTART Logo

HomeNews

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream

GlobeNewswire LogoGlobeNewswire22h ago

Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream - GlobeNewswire

Quick Summary:

A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), the fastest-growing professional skincare brand in the U.S.in 2024* and a subsidiary of Waldencast plc, (NASDAQ: WALD) ("Waldencast”), proudly introduces its latest breakthrough: Retinol + PHA Refining Night Cream.

A four-week clinical study demonstrated the efficacy of Retinol + PHA Refining Night Cream, with participants experiencing significant improvements in skin texture and tone, including: 29% increase in skin smoothness*10% improvement in skin tone evenness*90% of users reporting visibly smoother skin texture*90% observing a reduction in the appearance of blemishes* "At Obagi, our mission is to transform skin.

The brand continues to lead in physician-recommended skincare solutions and is recognized as the #1 Physician-Recommended Brand for At-Home Skincare Products for Hyperpigmentation, Fine Lines & Wrinkles, and Sagging Skin & Loss of Elasticity.** More information about Obagi is available on the brand’s website, *Among the Top 10 Professional Skin Care Brands in the U.S., According to Kline’s 2024 Global Professional Skin Care Series (China, Europe and the U.S.) **According to Kline’s Physician- Dispensed Skin Care: U.S.

or

Article Details

Author / Journalist: Waldencast plc.

Category: Technology

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-22 @ 12:30:00 (22 hours ago)

News Timezone: GMT +8:00

News Source URL: globenewswire.com

Language: English

Article Length: 726 words

Reading Time: 5 minutes read

Sentences: 27 lines

Sentence Length: 27 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © GlobeNewswire

News ID: 28148585

View Article Analysis

About GlobeNewswire

Main Topics: Technology

Official Website: globenewswire.com

Update Frequency: 87 posts per day

Year Established: 1998

Headquarters: China

News Last Updated: 13 hours ago

Coverage Areas: China

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #116

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream" has 726 words across 27 sentences, which will take approximately 4 - 7 minutes for the average person to read.

Which news outlet covered this story?

The story "Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream" was covered 22 hours ago by GlobeNewswire, a news publisher based in China.

How trustworthy is 'GlobeNewswire' news outlet?

GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news.

The outlet is headquartered in China and publishes an average of 87 news stories per day.

It's most recent story was published 13 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #28148585
  • URL: https://beamstart.com/news/obagi-medical-announces-the-launch-17453252182979

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.